Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) — Free Cash Flow Generation Index
Hubei Biocause Heilen Pharmaceutical Co. Ltd. (301211) has a Free Cash Flow Generation Index of -0.44x as of September 2025. Free cash flow of CN¥-5.06 Million represents 0% of operating cash flow (CN¥11.57 Million). Read Hubei Biocause Heilen Pharmaceutical Co. debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Hubei Biocause Heilen Pharmaceutical Co. Ltd. Free Cash Flow Generation Index (2018–2025)
Historical FCF Generation Index trend for Hubei Biocause Heilen Pharmaceutical Co. Ltd. across 8 annual periods. Explore 301211 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Hubei Biocause Heilen Pharmaceutical Co. Ltd. (2018–2025)
Year-by-year Free Cash Flow Generation Index for Hubei Biocause Heilen Pharmaceutical Co. Ltd.. For the full company profile including market capitalisation, see market value of Hubei Biocause Heilen Pharmaceutical Co..
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | -5.93x | CN¥-44.78 Million | CN¥7.55 Million | CN¥52.33 Million | ▼ -733.5% |
| 2024 | -0.71x | CN¥-68.36 Million | CN¥96.07 Million | CN¥164.43 Million | ▼ -97.1% |
| 2023 | -0.36x | CN¥-49.47 Million | CN¥137.06 Million | CN¥186.53 Million | ▼ -151.8% |
| 2022 | 0.70x | CN¥174.84 Million | CN¥250.79 Million | CN¥75.95 Million | ▼ -16.0% |
| 2021 | 0.83x | CN¥102.92 Million | CN¥123.98 Million | CN¥21.07 Million | ▼ -6.7% |
| 2020 | 0.89x | CN¥108.28 Million | CN¥121.67 Million | CN¥13.39 Million | ▼ -2.5% |
| 2019 | 0.91x | CN¥339.98 Million | CN¥372.33 Million | CN¥32.34 Million | ▲ +36.1% |
| 2018 | 0.67x | CN¥51.11 Million | CN¥76.18 Million | CN¥25.08 Million | — |